Advancing Innovation in Dermatology, Inc.

Exciting News From our Premier Sponsor! We're thrilled to celebrate the news announced at this weekend's Dermatology Summit: LEO Pharma has entered into a pivotal partnership with Gilead Sciences to develop novel therapeutic programs targeting inflammatory diseases. This landmark collaboration will accelerate the development of oral STAT6 inhibitors, potentially offering new hope for patients with atopic dermatitis, asthma, and COPD. The preclinical data showing STAT6's potential in treating inflammatory conditions represents an exciting step forward in our collective mission to advance dermatological science and patient care. As longtime supporters of dermatological innovation, we're particularly excited about the possibilities this partnership opens up for the development of both oral and topical treatments. The combined expertise of these two pharmaceutical powerhouses promises to accelerate the journey from bench to bedside. Congratulations to both teams on this momentous partnership! We look forward to seeing how this collaboration will shape the future of inflammatory disease treatment. #AdvancingDerm #BiotechNews #Pharmaceuticals (Read the Press Report at the 🔗 in comments)

To All Our Dermatology Summit Attendees and Innovation Community: Thank you for being part of another remarkable Dermatology Summit. Your presence and engagement helped make this year's event a true success, bringing together the brightest minds in dermatology innovation, entrepreneurship, and investment. From our discussions on the state of aesthetics and medical dermatology, to the groundbreaking sessions on emerging therapies and AI applications in dermatology, the day was filled with invaluable insights and meaningful connections. Everyone’s participation enriches the ecosystem of dermatology innovation, and we're grateful for the dynamic community you help create. We look forward to seeing the collaborations and developments that emerge from the connections made at this year's Summit. Thank you again for being part of this important gathering. We look forward to welcoming you back next year as we continue to shape the future of dermatology together. Sign up for our newsletter to be informed of our Summit recap and other news at the  🔗 in comments! #AdvancingDerm #Innovation #Dermatology #DermSummit2025

We're thrilled to welcome our community tomorrow to the 2025 Dermatology Summit! The energy and innovation that you all bring to this gathering make it a cornerstone event in advancing skin health and patient care. We've curated an exciting program that spans the most pressing topics in our field - from emerging therapies and technological breakthroughs to market insights and entrepreneurial innovations. The day promises to be filled with meaningful discussions, valuable networking opportunities, and insights that will help shape the future of dermatology. What makes this Summit truly special is the diverse expertise you represent - from pioneering researchers and innovative entrepreneurs to strategic investors and industry leaders. These connections and collaborations born at the Summit continue to drive our field forward. We look forward to seeing you tomorrow and being part of the conversations that will define the next chapter in dermatology innovation. #DermSummit2025 #AdvancingDerm #Innovation #Dermatology

Join us for an exciting session at this Sunday’s Dermatology Summit: "Investing in Longevity with Skin in the Game" Get ready to explore the intersection of dermatological breakthroughs and investment opportunities. As the dermatology market continues to evolve beyond aesthetics into therapeutic innovations, we're bringing together visionary entrepreneurs, leading dermatologists, and strategic investors to discuss the future of funded entrepreneurship and innovation in skin health. Moderated by: Frederick Beddingfield MD, PhD, CEO with Rubedo Life Sciences Panel: Marta Garcia Torres, Vice President, Corporate Development & Strategy with Almirall; William Greene, MD, Chief Investment Officer with Hevolution Foundation; Uri Lopatin, MD, Operating Partner with Khosla Ventures; Michael Ringel, JD, PhD, Managing Director and Senior Partner with Boston Consulting Group (BCG); and Robert Nelsen, Co-Founder & Managing Director with ARCH Venture Partners Don't miss this opportunity to connect with key players who are shaping the future of dermatological medicine. Register at 🔗 in comments! #AdvancingDerm #DermSummit25 #BioTech #VentureCapital

Discover the Future of Dermatology at the 2025 Innovation Forum! When: March 6, 2025 Where: Orlando, Florida Join the Conversation That's Shaping Tomorrow's Dermatology. Immerse yourself in groundbreaking discussions on: • AI in Dermatology • Advances in Local Non-Surgical Treatments for Cutaneous Malignancy • Seeing the Skin in New Light • Personal Care Product Safety: The BPO Controversy & More Your Day Includes: • Morning Entrepreneur Bootcamp • Expert-Led Sessions • Engaging Networking Opportunities • Evening Reception 🔬 Connect with leading physicians, researchers, strategics, and innovators who are revolutionizing skin health. Register at 🔗 in comments! Special thanks to our Program Chairs: Michael Girardi, Justin M Ko, Adam Raff, M.D., Ph.D., and Steve Xu #AdvancingDerm #DIF2025

The Derm Summit is in just 4 more days! Join us for two exciting State of the Industry sessions that will provide comprehensive insights into both the Aesthetics and Medical sectors of dermatology. In our Aesthetics session, gain valuable perspectives from Scott Gottlieb, MD, Senior Fellow at the American Enterprise Institute for Public Policy Research and former FDA Commissioner, alongside Michael E. Meyers, Vice Chairman and Head of M&A and Strategic Advisory Services at H.C. Wainwright & Co., LLC. Their combined expertise in regulatory affairs, policy, and market dynamics promises to deliver crucial insights. In our Medical session, we're privileged to have Liav Abraham, Managing Director of Global Healthcare at UBS Securities, sharing expert analysis on the current state and future trajectory of medical dermatology. Don't miss these essential sessions that will provide you with deep insights into the dermatology industry landscape! Register to Join Us at the 🔗 In Comments #Dermatology #Innovation #AdvancingDerm #DermSummit2025

Thank you to our Supporting Sponsors for their invaluable contribution to the 2025 Dermatology Summit. Your ongoing commitment empowers us to create an outstanding event while furthering innovation in dermatology. We look forward to joining forces this Sunday to explore cutting-edge advances in skin health. Your support makes these important conversations and discoveries possible. AnaptysBio, Canfield Scientific, Innovaderm Research Inc., maruho medical, Evommune, Dow Development Laboratories, LLC (DDL), Takeda, Therapeutics Inc., MedPharm, Contract Pharmaceuticals Limited. #DermSummit2025 #AdvancingDerm #Innovation #Dermatology

Breaking! First patient dosed in novel atopic dermatitis microbiome trial. Concerto Biosciences has initiated a Phase 1 trial of ENS-002, a live biotherapeutic targeting atopic dermatitis through microbiome modulation. For dermatologists following developments in AD treatment, this represents a novel therapeutic approach beyond traditional immunomodulators. Stay tuned as we celebrate and spotlight innovations that are pushing boundaries and addressing unmet needs in patient care. Are you ready to connect, learn, and be inspired? Join us in January! #Dermatology #Innovation #EntrepreneurialShowcase #DermSummit2025

Incyte has announced promising results from its Phase 3 inMIND study, revealing that tafasitamab (Monjuvi®), in combination with lenalidomide and rituximab, significantly improves progression-free survival in patients with relapsed or refractory follicular lymphoma. Innovation knows no boundaries in medicine. That's why we at Advancing Innovation in Dermatology are excited to celebrate one of our sponsor Incyte's latest oncology breakthrough. Their success story resonates deeply with our community of physician entrepreneurs and innovators, showing how vision and persistence can transform patient care across medical specialties. #Innovation #PatientCare #MedicalAdvancements Press Release: https://lnkd.in/grAjqsXg

We’re thrilled to deepen our community’s knowledge on the various topics within dermatology innovation. Gaining FDA approval on treatments and drugs can be a tricky place to navigate. Thank you to our panel experts with the FDA for sharing their insights and guidance with us in this past webinar. Access our on demand content at the link below and explore this webinar touching on: 🔬 Scientific Advances: assessment techniques for topical drugs, integrating formulation science, sparse sampling methods, spectroscopy, and physical/chemical analysis. 💊 Bioavailability/Bioequivalence: critical processes behind the approval of generic drugs, including the importance of bioavailability and bioequivalence assessments 📚 Research Involvement: Discover how you can actively participate in the FDA’s research program through the GDUFA research initiatives. 🌍 Ecosystem Impact: Understand the significant role of generic topical drugs in the broader drug ecosystem within the United States. 🔗: https://lnkd.in/eh5knMQM 👇 To view the FDA’s full presentation on the science behind innovations in topical generic drug assessment, click the link in the comments below. #Dermatology #Innovation #Research #Resources #AdvancingDerm